Diplomat to Participate in Upcoming Investor Conferences

FLINT, Mich., Aug. 31, 2015 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, has announced that Phil Hagerman, Chairman & CEO, and Sean Whelan, CFO, will present at four upcoming investor conferences.

Mr. Hagerman and Mr. Whelan are scheduled to participate in the Wells Fargo 2015 Healthcare Conference in Boston on Wednesday, September 9, 2015 at 1:45 PM ET.

Mr. Hagerman and Mr. Whelan are also scheduled to participate in the Robert W. Baird 2015 Healthcare Conference in New York on Thursday, September 10, 2015 at 9:40 AM ET.

Mr. Hagerman and Mr. Whelan are scheduled to participate in the 6th Annual Credit Suisse Small/Mid Cap Conference in New York on Wednesday, September 16, 2015 at 1:10 PM ET.

Mr. Hagerman and Mr. Whelan are also scheduled to participate in the Morgan Stanley Global Healthcare Conference in New York on Friday, September 18, 2015 at 9:20 AM ET.

About Diplomat  Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients, and the rest falls into place." Today, that tradition continues -- always focused on improving patient care and clinical adherence. For more information visit www.diplomat.is. Follow us on Twitter and LinkedIn and like us on Facebook.

INVESTOR CONTACT:  Bob East, Westwicke Partners  443.213.0500 | [email protected]

MEDIA CONTACT:  Jenny Cretu, Diplomat  810.768.9370 | [email protected]

Logo - http://photos.prnewswire.com/prnh/20140928/148820

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/diplomat-to-participate-in-upcoming-investor-conferences-300134940.html

SOURCE Diplomat Pharmacy, Inc.